Sort
21,281 grants matching “influenza”
Self-administered microneedle patches for influenza vaccines
$1,410,179Richard W Compans · Emory University · U01 · FY2008 · AI
Portable Multiplexed LATE-PCR Influenza Test
$1,409,513Barry E Boyes · Smiths Detection, Inc. · U01 · FY2009 · AI
Development of drugs that target the M2 proton channel from the influenza A Virus
$1,408,915William F Degrado · University Of California, San Francisco · U01 · FY2012 · AI
Immunobiology and Virology of Influenza A Virus
$1,408,875Jonathan W Yewdell · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
Pandemic Influenza Translational Research and novel universal countermeasure development
$1,406,345Matthew Memoli · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI
Clinical and Biostatistics Core
$1,405,948Wilbur H. Chen · Univ Of Maryland, College Park · U19 · FY2022 · AI
CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS)
$1,405,016Adolfo Garcia-Sastre · Icahn School Of Medicine At Mount Sinai · N01 · FY2018 · AI
High-Throughput Molecular Profiling Core
$1,403,983Michael G Katze · Univ Of North Carolina Chapel Hill · U19 · FY2012 · AI
T Cell Memory to Pathogens: Generation and Function
$1,403,973Susan L Swain · Trudeau Institute, Inc. · P01 · FY2009 · AI
Comprehensive multimodal analysis of patients with neuroimmunological diseases
$1,402,526Bibiana Bielekova · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
Influenza Vaccine Development
$1,402,202Barney Graham · National Institute Of Allergy And Infectious Diseases · ZIA · FY2015 · AI
Influenza Vaccine Development
$1,402,202Barney Graham · National Institute Of Allergy And Infectious Diseases · ZIA · FY2014 · AI
Influenza Vaccine Development
$1,402,202Barney Graham · National Institute Of Allergy And Infectious Diseases · ZIA · FY2016 · AI
IP21-002, New Vaccine Surveillance Network
$1,402,123John V Williams · University Of Pittsburgh At Pittsburgh · U01 · FY2021 · IP
Facility Management, Maintenance and Operations Core
$1,401,116Sixto Manuel Leal · University Of Alabama At Birmingham · UC7 · FY2023 · AI
Emerging respiratory viruses - pathogenesis and countermeasures
$1,400,690Emmie De Wit · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
Section on High Resolution Optical Imaging
$1,400,493Hari Shroff · National Institute Of Biomedical Imaging And Bioengineering · ZIA · FY2014 · EB
RFA-IP-22-004, Michigan-Ford Initiative to Measure Vaccine Effectiveness (MFIVE): Seasonal Influenza, COVID-19 and Respiratory Virus Vaccines
$1,400,000Emily Toth Martin · University Of Michigan At Ann Arbor · U01 · FY2023 · IP
RFA-IP-22-004, Evaluating influenza, SARS-CoV-2, and other respiratory virus vaccine effectiveness in prevention of acute illness in Washington state 2022-2027
$1,400,000Karen J Wernli · Kaiser Foundation Health Plan Of Washington · U01 · FY2023 · IP
RFA-IP-22-004, Evaluating influenza, SARS-CoV-2, and other respiratory virus vaccine effectiveness in prevention of acute illness in Washington state 2022-2027
$1,400,000Karen J Wernli · Kaiser Foundation Health Plan Of Washington · U01 · FY2024 · IP
RFA-IP-22-004:Michigan-Ford Initiative to Measure Vaccine Effectiveness (MFIVE): Seasonal Influenza, COVID-19 and Respiratory Virus Vaccines
$1,400,000Emily Toth Martin · University Of Michigan At Ann Arbor · U01 · FY2024 · IP
DNA Based Generation of Avian Influenza virus Vaccines
$1,400,000Sanofi Pasteur, Inc. · UC1 · FY2000 · AI
RFA-IP-22-004, Component A _ Credible Effectiveness Measures of Seasonal Influenza, COVID-19 and Other Respiratory Virus Vaccines against Ambulatory Care for Acute Illness in Texas (and Component D).
$1,400,000Manjusha Gaglani · Baylor Research Institute · U01 · FY2024 · IP
Strengthening Influenza Surveillance (WHO/EMRO)
$1,400,000Hassan El-Mahdi El-Bushra · World Hlth Org- -E Mediterranean Office · U51 · FY2008 · CI
RFA-IP-22-004, Component A _ Credible Effectiveness Measures of Seasonal Influenza, COVID-19 and Other Respiratory Virus Vaccines against Ambulatory Care for Acute Illness in Texas (and Component D).
$1,400,000Manjusha Gaglani · Baylor Research Institute · U01 · FY2023 · IP